Steris | STE - Operating Profit

Stock Price
221.80
Daily Change
-1.72 -0.77%
Monthly
-0.71%
Yearly
-1.42%
Q2 Forecast
217.05

Steris reported $278M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
3M USD 1.55B 337M Mar/2026
Accuray USD 4.71M 6.86M Dec/2024
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
CONMED USD 36.62M 24.74M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Ecolab USD 786.6M 200K Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fortive USD 225.5M 65.9M Dec/2025
Getinge SEK 1.08B 900M Dec/2024
Globus Medical USD 181.31M 298.83M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Masimo USD 83.9M 300K Dec/2025
Olympus JPY 28B 5.56B Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Owens Minor USD 814K 28.08M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025